Encrypted login | home

Program Information

MCEBRT, A Monte Carlo Code for External Beam Treatment Plan Verifications


O Chibani

O Chibani1*, A Eldib1,2 , C Ma1 , (1) Fox Chase Cancer Center, Philadelphia, PA, (2) Al-Azhar University, Cairo

Presentations

SU-E-T-578 Sunday 3:00PM - 6:00PM Room: Exhibit Hall


Purpose: Present a new Monte Carlo code (MCEBRT) for patient-specific dose calculations in external beam radiotherapy. The code MLC model is benchmarked and real patient plans are re-calculated using MCEBRT and compared with commercial TPS.

Methods: MCEBRT is based on the GEPTS system (Med. Phys. 29 (2002) 835-846). Phase space data generated for Varian linac photon beams (6 - 15 MV) are used as source term. MCEBRT uses a realistic MLC model (tongue and groove, rounded ends). Patient CT and DICOM RT files are used to generate a 3D patient phantom and simulate the treatment configuration (gantry, collimator and couch angles; jaw positions; MLC sequences; MUs). MCEBRT dose distributions and DVHs are compared with those from TPS in absolute way (Gy).

Results: Calculations based on the developed MLC model closely matches transmission measurements (pin-point ionization chamber at selected positions and film for lateral dose profile). See Fig.1. Dose calculations for two clinical cases (whole brain irradiation with opposed beams and lung case with eight fields) are carried out and outcomes are compared with the Eclipse AAA algorithm. Good agreement is observed for the brain case (Figs 2-3) except at the surface where MCEBRT dose can be higher by 20%. This is due to better modeling of electron contamination by MCEBRT. For the lung case an overall good agreement (91% gamma index passing rate with 3%/3mm DTA criterion) is observed (Fig.4) but dose in lung can be over-estimated by up to 10% by AAA (Fig.5). CTV and PTV DVHs from TPS and MCEBRT are nevertheless close (Fig.6).

Conclusion: A new Monte Carlo code is developed for plan verification. Contrary to phantom-based QA measurements, MCEBRT simulate the exact patient geometry and tissue composition. MCEBRT can be used as extra verification layer for plans where surface dose and tissue heterogeneity are an issue.


Contact Email: